Archan Ruparel to speak as a panelist on an ABA Webinar titled “Proving But-for Entry Dates in Pharmaceutical Antitrust Litigation.”
A question arises in most pharmaceutical antitrust cases: when would generic entry have occurred absent the accused conduct? In this program, a panel of experienced economists and attorneys who have addressed these issues from discovery to trial will discuss approaches to proving but-for entry dates. They will illustrate the economic models and evidence used to support and dispute entry dates.
Moderator: Danielle Foley (Venable)
Speaker 1: Keith Leffler (University of Washington)
Speaker 2: Archan Ruparel (Charles River Associates)
Speaker 3: Abbye Klamann Ognibene (Hagens Berman)
Sponsored by the ABA Antitrust Section Health Care and Pharmaceuticals Committee.
